Suchergebnisse - "Meyer, Antoine"

PubPharm (6)

1

Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors : a multicenter case series

enthalten in: Journal of gastroenterology and hepatology | 2023

von Bresteau, C. | Bonnet, P. | Robert, C. | +10

2

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF

enthalten in: RMD open | 2022

von Cachen, L. | Nocturne, G. | Collins, M. | +6

3

Editorial : subcutaneous CT-P13 in Crohn's disease and ulcerative colitis-small change, big consequences

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Carbonnel, F. | Meyer, A.

CommentOn: Aliment Pharmacol Ther. 2021 Nov;54(10):1309-1319. - PMID 34559426

4

Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis : A GETAID cohort

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Uzzan, M. | Bresteau, C. | Laharie, D. | +49

CommentIn: Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. - PMID 34236096

5

The effectiveness and safety of infliximab compared with biosimilar CT-P13, in 3112 patients with ulcerative colitis

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Meyer, A. | Rudant, J. | Drouin, J. | +3

6

Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease : A French Equivalence Study

enthalten in: Annals of internal medicine | 2019

von Meyer, A. | Rudant, J. | Drouin, J. | +3

1
[1]